Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Schizophrenia: a biochemical disorder?

D F Horrobin

    Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
    |May 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Schizophrenia may involve dopamine, prostaglandin, and opioid imbalances. Niacin

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A Diet Enriched in α-Lipoic Acid Reverses the Age-Related Compromise in Antioxidant Defences in Rat Cortical Tissue.

    Nutritional neuroscience·2016
    Same author

    Prostaglandins and the ductus arteriosus.

    Canadian Medical Association journal·2010
    Same author

    Thromboxane A(2) as a possible natural ligand for benzodiazepine receptors.

    Neuroscience letters·2009
    Same author

    The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats.

    Pharmacopsychiatry·2006
    Same author

    Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial.

    Neurology·2005
    Same author

    Cerebral metabolism in male patients with schizophrenia who have seriously and dangerously violently offended: a 31P magnetic resonance spectroscopy study.

    Prostaglandins, leukotrienes, and essential fatty acids·2004
    Same journal

    Characterization of a major natural killer activity in rat lungs.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    Decreased phagocytosis and antibody-dependent cellular cytotoxicity (ADCC) in type-1 diabetes.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    [Alveolar macrophages in asthmatic patients: study of their phagocytic function].

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    Effect of salbutamol, a putative cerebral beta agonist on sleep stages and interictal epileptic discharges.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    Ganglioside content and pattern in tumor tissue of human neuroblastomas.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    Protective effect of levamisole on carbon tetrachloride-induced lipid peroxidation and hepatotoxicity.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    See all related articles

    Area of Science:

    • Biochemistry
    • Neuroscience
    • Psychiatry

    Background:

    • Schizophrenia is potentially linked to dopamine hyperactivity.
    • Evidence suggests a role for prostaglandin deficiency and opioid system alterations.
    • These factors may be interconnected through biochemical pathways.

    Purpose of the Study:

    • To explore the interrelationship between dopamine, prostaglandins, and opioids in schizophrenia.
    • To investigate niacin's effect on prostaglandin synthesis as a potential diagnostic marker.

    Main Methods:

    • Review of existing evidence on dopamine, prostaglandin E1, and opioid interactions.
    • Analysis of niacin-induced flushing response in schizophrenic patients compared to controls.

    Main Results:

    Related Experiment Videos

    • Opioids can inhibit prostaglandin E1 synthesis; dopamine and prostaglandin E1 reciprocally affect each other.
    • Low prostaglandin E1 levels may manifest as apparent dopamine excess.
    • Schizophrenic individuals require significantly higher oral niacin doses for flushing compared to healthy individuals.

    Conclusions:

    • A biochemical link between dopamine, prostaglandins, and opioids may underlie schizophrenia.
    • The blunted niacin-induced flushing response in schizophrenics suggests a prostaglandin deficiency.
    • This niacin response could serve as a simple biochemical test for a significant subset of schizophrenia patients.